{"id":198213,"date":"2024-10-19T12:37:04","date_gmt":"2024-10-19T12:37:04","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/aami-10993-10-2010-ra-2014\/"},"modified":"2024-10-25T05:10:14","modified_gmt":"2024-10-25T05:10:14","slug":"aami-10993-10-2010-ra-2014","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/aami\/aami-10993-10-2010-ra-2014\/","title":{"rendered":"AAMI 10993 10 2010 RA 2014"},"content":{"rendered":"
Describes the procedure for the assessment of medical devices and their constituent materials with regard to their potential to produce irritation and skin sensitization. Includes: a) pretest considerations for irritation, including in silico and in vitro methods for dermal exposure; b) details of in vivo (irritation and sensitization) test procedures, and; c) key factors for the interpretation of the results. Instructions are given in Annex A for the preparation of materials specifically in relation to the above tests. In Annex B several special irritation tests are described for application of medical devices in areas other than skin.<\/p>\n
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
1<\/td>\n | ANSI\/AAMI\/ISO 10993-10:2010\/(R)2014, Biological evaluation of medical devices \u2014 Part 10: Tests for irritation and skin sensitization <\/td>\n<\/tr>\n | ||||||
2<\/td>\n | Objectives and uses of AAMI standards and recommended practices <\/td>\n<\/tr>\n | ||||||
3<\/td>\n | Title page <\/td>\n<\/tr>\n | ||||||
4<\/td>\n | AAMI Standard Copyright information <\/td>\n<\/tr>\n | ||||||
5<\/td>\n | Contents <\/td>\n<\/tr>\n | ||||||
6<\/td>\n | Glossary of equivalent standards <\/td>\n<\/tr>\n | ||||||
8<\/td>\n | Committee representation <\/td>\n<\/tr>\n | ||||||
10<\/td>\n | Background of ANSI\/AAMI adoption of ISO 10993-10:2010 <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
15<\/td>\n | 1 Scope 2 Normative references <\/td>\n<\/tr>\n | ||||||
16<\/td>\n | 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
18<\/td>\n | 4 General principles\u00a0\u2014 Step-wise approach <\/td>\n<\/tr>\n | ||||||
19<\/td>\n | 5 Pretest considerations 5.1 General 5.2 Types of material 5.2.1 Initial considerations 5.2.2 Ceramics, metals and alloys <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | 5.2.3 Polymers 5.2.4 Biologically derived materials 5.3 Information on chemical composition 5.3.1 General 5.3.2 Existing data sources <\/td>\n<\/tr>\n | ||||||
21<\/td>\n | 6 Irritation tests 6.1 In\u00a0vitro irritation tests 6.2 In\u00a0vivo irritation tests\u00a0\u2014 Factors to be considered in design and selection of in\u00a0vivo tests <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | 6.3 Animal irritation test 6.3.1 Principle 6.3.2 Test material 6.3.3 Animals and husbandry <\/td>\n<\/tr>\n | ||||||
23<\/td>\n | 6.3.4 Test procedure 6.3.4.1 Preparation of animals 6.3.4.2 Application of test sample 6.3.4.2.1 Application of powder or liquid sample <\/td>\n<\/tr>\n | ||||||
24<\/td>\n | 6.3.4.2.2 Application of extracts and extract vehicle 6.3.4.2.3 Application of solid sample <\/td>\n<\/tr>\n | ||||||
25<\/td>\n | 6.3.5 Observation of animals 6.3.5.1 General 6.3.5.2 Single-exposure test 6.3.5.3 Repeated-exposure test 6.3.6 Evaluation of results <\/td>\n<\/tr>\n | ||||||
26<\/td>\n | 6.3.7 Test report 6.4 Animal intracutaneous (intradermal) reactivity test 6.4.1 Introduction <\/td>\n<\/tr>\n | ||||||
27<\/td>\n | 6.4.2 Exclusion from test 6.4.3 Test sample 6.4.4 Animals and husbandry 6.4.5 Test procedure <\/td>\n<\/tr>\n | ||||||
28<\/td>\n | 6.4.6 Observation of animals <\/td>\n<\/tr>\n | ||||||
29<\/td>\n | 6.4.7 Evaluation of results 6.4.8 Test report <\/td>\n<\/tr>\n | ||||||
30<\/td>\n | 6.5 Human skin irritation test 6.5.1 Introduction 6.5.2 Initial considerations <\/td>\n<\/tr>\n | ||||||
31<\/td>\n | 7 Skin sensitization tests 7.1 Choice of test methods 7.2 Murine Local Lymph Node Assay (LLNA) 7.2.1 Principle 7.2.2 Test sample preparation <\/td>\n<\/tr>\n | ||||||
32<\/td>\n | 7.2.3 Animals and husbandry 7.2.4 Test procedure <\/td>\n<\/tr>\n | ||||||
33<\/td>\n | 7.2.5 Treatment groups 7.2.6 Determination of cellular proliferation and tissue preparation <\/td>\n<\/tr>\n | ||||||
34<\/td>\n | 7.2.7 Results and interpretation 7.2.8 Test report <\/td>\n<\/tr>\n | ||||||
35<\/td>\n | 7.3 Guinea pig assays for the detection of skin sensitization 7.3.1 Principle 7.3.2 Choice of test sample concentrations 7.3.3 Induction 7.3.4 Challenge 7.4 Important factors affecting the outcome of the test <\/td>\n<\/tr>\n | ||||||
36<\/td>\n | 7.5 Guinea pig maximization test (GPMT) 7.5.1 Principle 7.5.2 Test sample preparation 7.5.3 Animals and husbandry <\/td>\n<\/tr>\n | ||||||
37<\/td>\n | 7.5.4 Test procedure 7.5.4.1 Preparation 7.5.4.2 Preliminary tests <\/td>\n<\/tr>\n | ||||||
38<\/td>\n | 7.5.4.3 Main test 7.5.4.3.1 Intradermal induction phase 7.5.4.3.2 Topical induction phase <\/td>\n<\/tr>\n | ||||||
39<\/td>\n | 7.5.4.3.3 Challenge phase 7.5.5 Observation of animals 7.5.6 Evaluation of results 7.5.7 Test report <\/td>\n<\/tr>\n | ||||||
40<\/td>\n | 7.6 Closed-patch test (Buehler test) 7.6.1 Principle 7.6.2 Test sample preparation 7.6.3 Animals and husbandry 7.6.4 Test procedure 7.6.4.1 Preparation 7.6.4.2 Preliminary tests <\/td>\n<\/tr>\n | ||||||
41<\/td>\n | 7.6.4.3 Main test 7.6.4.3.1 Induction phase 7.6.4.3.2 Challenge phase 7.6.5 Observation of animals <\/td>\n<\/tr>\n | ||||||
42<\/td>\n | 7.6.6 Evaluation of results 7.6.7 Test report 8 Key factors in interpretation of test results <\/td>\n<\/tr>\n | ||||||
44<\/td>\n | Annex A Preparation of materials for irritation\/sensitization testing A.1 General A.2 Materials for direct-contact exposure A.2.1 Solid test materials A.2.2 Liquid test materials A.3 Extracts of test materials <\/td>\n<\/tr>\n | ||||||
45<\/td>\n | A.4 Solvents A.5 Sterile test materials <\/td>\n<\/tr>\n | ||||||
46<\/td>\n | Annex B Special irritation tests B.1 General B.2 Ocular irritation test B.2.1 General B.2.2 Principle B.2.3 Exclusion from test B.2.4 Test material <\/td>\n<\/tr>\n | ||||||
47<\/td>\n | B.2.5 Animals and husbandry B.2.6 Test procedure B.2.7 Observation of animals <\/td>\n<\/tr>\n | ||||||
50<\/td>\n | B.2.8 Evaluation of results <\/td>\n<\/tr>\n | ||||||
51<\/td>\n | B.2.9 Test report B.3 Oral mucosa irritation test B.3.1 General B.3.2 Principle B.3.3 Exclusion from test B.3.4 Test material B.3.5 Animals and husbandry <\/td>\n<\/tr>\n | ||||||
52<\/td>\n | B.3.6 Test procedure B.3.7 Observation of animals <\/td>\n<\/tr>\n | ||||||
53<\/td>\n | B.3.8 Assessment of results B.3.8.1 Macroscopic evaluation B.3.8.2 Histological evaluation <\/td>\n<\/tr>\n | ||||||
54<\/td>\n | B.3.9Test report <\/td>\n<\/tr>\n | ||||||
56<\/td>\n | B.4 Penile irritation test B.4.1 General B.4.2 Principle B.4.3 Exclusion from test B.4.4 Test sample B.4.5 Animals and husbandry B.4.6 Test procedure <\/td>\n<\/tr>\n | ||||||
57<\/td>\n | B.4.7 Observation of animals B.4.8 Assessment of results B.4.8.1 Macroscopic evaluation B.4.8.2 Histological evaluation <\/td>\n<\/tr>\n | ||||||
58<\/td>\n | B.4.9 Test report B.5 Rectal irritation test B.5.1 General B.5.2 Principle B.5.3 Exclusion from test B.5.4 Test material B.5.5 Animals and husbandry <\/td>\n<\/tr>\n | ||||||
59<\/td>\n | B.5.6 Test procedure B.5.7 Observation of animals B.5.8 Evaluation of results B.5.8.1 Macroscopic evaluation <\/td>\n<\/tr>\n | ||||||
60<\/td>\n | B.5.8.2 Histological evaluation B.5.9 Test report B.6 Vaginal irritation test B.6.1 General <\/td>\n<\/tr>\n | ||||||
61<\/td>\n | B.6.2 Principle B.6.3 Exclusion from test B.6.4 Test material B.6.5 Animals and husbandry B.6.6 Test procedure <\/td>\n<\/tr>\n | ||||||
62<\/td>\n | B.6.7 Observation of animals B.6.8 Evaluation of results B.6.8.1 Macroscopic evaluation B.6.8.2 Histological evaluation B.6.9 Test report <\/td>\n<\/tr>\n | ||||||
64<\/td>\n | Annex C Human skin irritation test C.1 General C.2 Principle C.3 Description of the method C.3.1 Selection of human volunteers C.3.2 Preparation of doses <\/td>\n<\/tr>\n | ||||||
65<\/td>\n | C.3.3 Procedure C.3.3.1 Number of volunteers C.3.3.2 Application of the test material C.3.3.3 Duration of exposure C.3.3.4 Limited exposure C.3.3.5 Clinical observation and grading of skin reactions <\/td>\n<\/tr>\n | ||||||
66<\/td>\n | C.3.3.6 Rationale for and selection of a concurrent positive control substance C.4 Data and reporting C.4.1 Data C.4.2 Data evaluation\/interpretation <\/td>\n<\/tr>\n | ||||||
67<\/td>\n | C.4.3 Test report <\/td>\n<\/tr>\n | ||||||
68<\/td>\n | Annex D In vitro tests for skin irritation D.1 Background information <\/td>\n<\/tr>\n | ||||||
69<\/td>\n | D.2 Principle of the in vitro skin irritation tests D.2.1 General D.2.2 General model characteristics D.2.3 Functional model requirements D.2.3.1 General D.2.3.2 Viability <\/td>\n<\/tr>\n | ||||||
70<\/td>\n | D.2.3.3 Barrier function D.2.3.4 Morphology D.2.3.5 Reproducibility D.2.3.6 Quality controls (QC) of the model D.3 Test material <\/td>\n<\/tr>\n | ||||||
71<\/td>\n | D.4 Test procedures <\/td>\n<\/tr>\n | ||||||
72<\/td>\n | D.5 Results and interpretation <\/td>\n<\/tr>\n | ||||||
73<\/td>\n | D.6 Test report <\/td>\n<\/tr>\n | ||||||
74<\/td>\n | Annex E Method for the preparation of extracts from polymeric test materials E.1 General E.2 Preparation method E.2.1 Preliminary extraction E.2.2 Final extraction E.2.2.1 General <\/td>\n<\/tr>\n | ||||||
75<\/td>\n | E.2.2.2 Test sample preparation according to Method 1 E.2.2.3 Test sample preparation according to Method 2 <\/td>\n<\/tr>\n | ||||||
76<\/td>\n | E.3 Guinea pig maximization test (GPMT) E.3.1 General E.3.2 Challenge phase <\/td>\n<\/tr>\n | ||||||
77<\/td>\n | Annex F Background information F.1 Irritation tests <\/td>\n<\/tr>\n | ||||||
78<\/td>\n | F.2 Sensitization tests for skin sensitization <\/td>\n<\/tr>\n | ||||||
81<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" ANSI\/AAMI\/ISO 10993-10:2010\/(R)2014 – Biological evaluation of medical devices-Part 10: Tests for irritation and skin sensitization<\/b><\/p>\n |